We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
  1. You have to credit our authors.
  2. You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
  3. You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
  4. If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
  5. The easiest way to get the article on your site is to embed the code below.
For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

The South African Treatment Access Campaign (TAC) has today won a landmark court case against the South African government on the issue of mother-to-child HIV transmission. TAC had demanded that all HIV-positive pregnant women are given a course of treatment of nevirapine, a drug that reduces mother-to-child transmission.

In his ruling, Judge Chris Botha of the Pretoria High Court ordered the government to “make Nevirapine available to pregnant women with HIV who give birth in the public sector, and to their babies”.

Sipho Mthathi of TAC said “The government has failed women with HIV/AIDS, children and all people in our country. Now, it has the opportunity to heal the wounds caused by its lack of action”. Mthathi also warned that the “government has a choice: work with TAC or face an unprecedented national and international mobilisation”.

© SciDev.Net 2001

Related external link:

SA ordered to provide Aids drugs (BBC Online)

Related topics